Other important biomarkers involve the secretion of proteolytic enzymes (e.g., GzmA and GzmB), which are key effector molecules in cytotoxic T cells and can be used for real-time monitoring of anti-cancer immunotherapy efficacy. This evidence concerns the gene GZMA and cancer.